Baseline risk factor | Hazard ratio | 95 % hazard ratio confidence limits | P value | |
---|---|---|---|---|
Lower | Upper | |||
Age above 60 years | 2.85 | 0.97 | 8.41 | 0.058 |
Male sex | 4.10 | 1.41 | 11.92 | 0.010 |
Poor performance | 5.36 | 1.56 | 18.41 | 0.008 |
Stage (III–IV) | 0.44 | 0.13 | 1.42 | 0.169 |
Extranodal involvement | 1.32 | 0.34 | 5.07 | 0.687 |
B symptoms | 1.80 | 0.68 | 4.80 | 0.238 |
Not treated with rituximab | 0.55 | 0.15 | 2.10 | 0.383 |
Elevated LDH | 0.73 | 0.26 | 2.06 | 0.553 |
DAPK1 methylation | 8.93 | 2.72 | 29.31 | 0.0007 |